Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Multicentre, randomised, parallel group, placebo-controlled, double-blind, study, stratified on tobacco status at enrollment, evaluating during 6 months the efficacy of salmeterol powder for inhalation, 50 µg two times per day for the reduction of thoracic distension in subjects with chronic ob ...
salmeterol
SLMF4010
N/A
Pulmonary Disease, Chronic Obstructive
Phase 4
 
All or some of the data and documents for this study are in a non-English language and anonymisation may take longer. An annotated case report form is not available for this study. A blank case report form will be provided. A link to Clinicaltrials.gov and a NCT ID number are not available for this study because the study was conducted before regulatory requirements to register studies.
September 2013

Powered by ideaPoint, Inc.